Hip Arthroplasty for Severe Ankylosing Spondylitis: case report
DOI: 10.32364/2587-6821-2025-9-3-6
S.A. Lapshina, I.F. Akhtyamov, K.R. Zagretdinova, A.R. Yuskaeva, M. Al-Lami
Kazan State Medical University, Kazan, Russian Federation
The paper is focused on a case study in a 52-year-old patient with a long history of ankylosing spondylitis (AS) after bilateral hip arthroplasty. The clinical picture and course of the disease are characterized by an advanced stage of the pathological process with obvious severe structural changes of the axial skeleton and occurrence of articular syndrome in 10 years after the disease onset. The lack of a clear clinical presentation at the early stage and rapid progression associated with terminal lesions of the hip joints and spine determined the difficulties of timely diagnosis and management of the patient. As the structural lesion of the axial skeleton progressed and the patient's quality of life significantly deteriorated, the treatment strategy included genetically engineered biological therapy and total joint arthroplasty resulted in a subsequent decrease in the laboratory and clinical activity of the disease, as well as significant improvement in the function of the hip joints and the patient's quality of life. According to the literature data, the AS-associated lesion of the hip joints is a predictor of an unfavourable course (severe structural changes of the axial skeleton and rapid progression of the pathological autoinflammatory process) which subsequently requires joint management of a patient by a rheumatologist and an orthopaedist in order to control clinical and laboratory activity of the disease, as well as to improve the quality of life.
Keywords: clinical case, ankylosing spondylitis, coxitis, hip arthroplasty, genetically engineered biological therapy.
For citation: Lapshina S.A., Akhtyamov I.F., Zagretdinova K.R., Yuskaeva A.R., Al-Lami M. Hip Arthroplasty for Severe Ankylosing Spondylitis: case report. Russian Medical Inquiry. 2025;9(3):182–187 (in Russ.). DOI: 10.32364/2587-6821-2025-9-3-6
About the authors:
Svetlana A. Lapshina — C. Sc. (Med.), Assistant Professor of the Department of Hospital Therapy, Kazan State Medical University; 49, Butlerov str., Kazan, 420012, Russian Federation; ORCID iD 0000-0001-5474-8565
Ildar F. Akhtyamov — Professor, Dr. Sc. (Med.), Head of the Department of Traumatology, Orthopedics and Surgery of Emergency States, Kazan State Medical University; 49, Butlerov str., Kazan, 420012, Russian Federation; ORCID iD 0000-0002-4910-8835
Karina R. Zagretdinova — Resident Physician of the Department of Hospital Therapy, Kazan State Medical University; 49, Butlerov str., Kazan, 420012, Russian Federation; ORCID iD 0009-0001-2118-8087
Alina R. Yuskaeva — Postgraduate Student of the Department of Hospital Therapy, Kazan State Medical University; 49, Butlerov str., Kazan, 420012, Russian Federation; ORCID iD 0000-0002-8254-652X
Mustafa A.J. Al-Lami — Teaching Assistant of the Department of Traumatology, Orthopedics and Surgery of Emergency States, Kazan State Medical University; 49, Butlerov str., Kazan, 420012, Russian Federation; ORCID iD 0000-0002-4941-8374
Contact information: Svetlana A. Lapshina, e-mail: svetlanalapshina@mail.ru
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 02.09.2024.
Revised 25.09.2024.
Accepted 18.10.2024.
2. Гайдукова И.З., Мазуров В.И. Патогенез аксиальных спондилоартритов как основа лечения — реалии и перспективы. РМЖ. 2023;7:6–14.Gaydukova I.Z., Mazurov V.I. Pathogenesis of axial spondyloarthritis as the treatment basis — realities and prospects. RMJ. 2023;7:6–14 (in Russ.).
3. Агафонова Е.М., Дубинина Т.В., Демина А.Б. и др. Особенности лечения коксита у пациентов с анкилозирующим спондилитом. Современная ревматология. 2018;12(2):88–92. DOI: 10.14412/1996-7012-2018-2-88-92Agafonova E.M., Dubinina T.V., Dyomina A.B. et al. Features of coxitis treatment in patients with ankylosing spondylitis. Modern Rheumatology Journal. 2018;12(2):88–92 (in Russ.). DOI: 10.14412/1996-7012-2018-2-88-92
4. Бабаева А.Р., Калинина Е.В., Звоноренко М.С. и др. Патогенетические и клинические аспекты блокады интерлейкина-17 при спонди-лоартритах. Медицинский алфавит. 2020;(15):5–9. DOI: 10.33667/2078-5631-2020-15-5-9Babaeva A.R., Kalinina E.V., Zvonorenko M.S. et al. Pathogenetic and clinical aspects of interleukin-17 blockade in spondyloarthritis. Medical alphabet. 2020;(15):5–9. DOI: 10.33667/2078-5631-2020-15-5-9
5. Агафонова Е.М., Дубинина Т.В., Демина А.Б. и др. Особенности инструментальной диагностики коксита при анкилозирующем спондилите в реальной клинической практике. Научно-практическая ревматология. 2018;56(6):716–721. DOI: 10.14412/1995-4484-2018-716-721Agafonova E.M., Dubinina T.V., Demina A.B. et al. Instrumental diagnosis of coxitis in ankylosing spondylitis in real clinical practice. Rheumatology Science and Practice. 2018;56(6):716–721 (in Russ.). DOI: 10.14412/1995-4484-2018-716-721
6. Boonen A., van der Cruyssen B., De Vlam K. et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009;36(6):1249–1255. DOI: 10.3899/jrheum.080831
7. Vander Cruyssen B., Muñoz-Gomariz E., Font P. et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49(1):73–81. DOI: 10.1093/rheumatology/kep174
8. Mazzucchelli R., Almodóvar R., Turrado-Crespí P. et al. Trends in orthopaedic surgery for spondyloarthritis: outcomes from a National Hospitalised Patient Registry (MBDS) over a 17-year period (1999-2015). TREND-EspA study. RMD Open. 2022;8(1):e002107. DOI: 10.1136/rmdopen-2021-002107
9. Li L., Fu J., Xu C. et al. Hip Replacement in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Factors Associated with Bilateral Total Hip Arthroplasty. Int J Gen Med. 2021;14:6857–6862. DOI: 10.2147/ijgm.s336314
10. Li L.L., Fu J., Xu C. et al. Gender Differences in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Results from A Matched Retrospective Cohort Study. Orthop Surg. 2022;14(2):405–410. DOI: 10.1111/os.13123
11. Подряднова М.В., Балабанова Р.М., Урумова М.М., Эрдес Ш.Ф. Коксит при анкилозирующем спондилите: сопоставление клинических проявлений с данными ультразвукового исследования. Научно-практическая ревматология. 2014;52(4):417–422. Podryadnova M.V., Balabanova R.M., Urumova M.M., Erdes Sh.F. Coxitis in ankylosing spondylitis: Comparison of clinical manifestations with ultrasound study data. Rheumatology Science and Practice. 2014;52(4):417–422 (in Russ.).
12. Goodman S.M., Springer B.D., Chen A.F. et al. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res. 2022;74(9):1399–1408.
13. Iyer P., Hwang M., Ridley L., Weisman M.M. Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with. RMD Open. 2023;9(4):e003372. DOI: 10.1136/rmdopen-2023-003372
14. Danve A., Deodhar A. Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol. 2022;18(4):205–216. DOI: 10.1038/s41584-022-00761-z
15. Ramiro S., Nikiphorou E., Sepriano A. et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19–34. DOI: 10.1136/ard-2022-223296
16. Baraliakos X., Gensler L.S., D'Angelo S. et al. Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review. Ther Adv Musculoskelet Dis. 2020;12:1759720X20906040. DOI: 10.1177/1759720X20906040
17. Atzeni F., Carriero A., Boccassini L., D'Angelo S. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. Immunotargets Ther. 2021;10:141–153. DOI: 10.2147/ITT.S259126
18. Yin Y., Wang M, Liu M. et al. Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Res Ther. 2020;22(1):111. DOI: 10.1186/s13075-020-02208-w
19. Kiaer T., Gehrchen M. Transpedicular closed wedge osteotomy in ankylosing spondylitis: results of surgical treatment and prospective outcome analysis. Eur Spine J. 2010;19(1):57–64. DOI: 10.1007/s00586-009-1104-8
20. Бочкова А.Г., Румянцева О.А., Северинова М.В. и др. Коксит у больных анкилозирующим спондилитом: клинико-рентгенологические сопоставления. Научно-практическая ревматология. 2005;43(4):8–12. DOI: 10.14412/1995-4484-2005-610Bochkova A.G., Rumyantseva O.A., Severinova M.V. et al. Coxitis in patients with ankylosing spondylitis: clinicoradio logic comparisons. Rheumatology Science and Practice. 2005;43(4):8–12 (in Russ.). DOI: 10.14412/1995-4484-2005-610
21. Дубинина Т.В., Гайдукова И.З., Годзенко А.А. и др. Рекомендации по оценке активности болезни и функционального состояния больных анкилозирующим спондилитом в клинической практике. Научно-практическая ревматология. 2017;55(4):344–350. DOI: 10.14412/1995-4484-2017-344-350Dubinina T.V., Gaidukova I.Z., Godzenko A.A. et al. Guidelines for the assessment of disease activity and functional status in patients with ankylosing spondylitis in clinical practice. Rheumatology Science and Practice. 2017;55(4):344–350 (in Russ.). DOI: 10.14412/1995-4484-2017-344-350
22. Guan M., Wang J., Zhao L. et al. Management of hip involvement in ankylosing spondylitis. Clin Rheumatol. 2013;32(8):1115–1120. DOI: 10.1007/s10067-013-2278-3
23. Saglam Y., Ozturk I., Cakmak M.F. et al. Total hip arthroplasty in patients with ankylosing spondylitis: Midterm radiologic and functional results. Acta Orthop Traumatol Turc. 2016;50(4):443–447. DOI: 10.1016/j.aott.2016.06.010
24. Ding L., Gao Y.H., Li Y.R. et al. Determinants of satisfaction following total hip arthroplasty in patients with ankylosing spondylitis. Int Orthop. 2018;42(3):507–511. DOI: 10.1007/s00264-017-3589-9
25. Blizzard D.J., Penrose C.T., Sheets C.Z. et al. Ankylosing Spondylitis Increases Perioperative and Postoperative Complications After Total Hip Arthroplasty. J Arthroplasty. 2017;32(8):2474–2479. DOI: 10.1016/j.arth.2017.03.041
This work is licensed under a Creative Commons «Attribution» 4.0 License.
